In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to EACVI Silver Members, Fellows of the ESC and Young combined Members

4D flow CMR for diastolic function assessment in cardiac amyloidosis

Session Rapid Fire Abstract 6: 4D flow and valvular heart disease: can CMR add value?

Speaker Filippo Piatti

Event : EuroCMR 2019

  • Topic : imaging
  • Sub-topic : Cardiac Magnetic Resonance: Flow Imaging
  • Session type : Rapid Fire Abstracts

Authors : S Pica (Milan,IT), F Piatti (San Donato Milanese,IT), P Milani (Pavia,IT), R Mussinelli (Pavia,IT), A Foli (Pavia,IT), M Basset (Pavia,IT), A Camporeale (Milan,IT), C Geppert (Erlangen,DE), D Giese (Erlangen,DE), K Chow (Erlangen,DE), S Perlini (Pavia,IT), G Merlini (Pavia,IT), G Palladini (Pavia,IT), M Lombardi (Milan,IT)

Authors:
S Pica1 , F Piatti2 , P Milani3 , R Mussinelli3 , A Foli3 , M Basset3 , A Camporeale1 , C Geppert4 , D Giese4 , K Chow4 , S Perlini3 , G Merlini3 , G Palladini3 , M Lombardi1 , 1IRCCS Polyclinic San Donato, Multimodality Cardiac Imaging - Milan - Italy , 2IRCCS, Policlinico San Donato, 3D and Computer Simulation Laboratory - San Donato Milanese - Italy , 3Amyloidosis Research and Treatment Center, Department of Molecular Medicine University of Pavia - Pavia - Italy , 4Siemens Healthcare GmbH - Erlangen - Germany ,

Citation:
European Heart Journal - Cardiovascular Imaging ( 2019 ) 20 ( Supplement 2 ), ii408

Background. Cardiac involvement (CI) due to systemic light-chain amyloidosis leads to LV diastolic and systolic dysfunction, culminating with end-stage heart failure. Brain natriuretic peptides and echocardiography are commonly used for diagnosis and prognosis; CMR is becoming a standard to diagnose and track CI changes thanks to tissue characterization by late gadolinium enhancement (LGE) and T1 mapping. 4DFlow is a new technique that can quantitively assess LV 3D blood flow properties over the cardiac cycle with novel markers of diastolic dysfunction, superior to other techniques because of lack of restriction to imaging planes, high isotropic spatial resolution, low operator dependency. Specifically, quantification and timing of mechanical stimuli (wall shear stress, WSS) that blood flow exerts on LV wall and changes in blood momentum (hemodynamic forces, HF) during LV relaxation.

Aim. To compare LV diastolic function assessed by 4DFlow in pts with cardiac amyloidosis vs controls and to correlate 4DFlow markers with tissue characterization, echocardiographic and laboratory parameters.

Methods. A group of pts with cardiac amyloidosis defined by echocardiography underwent a comprehensive clinical, laboratory, CMR assessment with LGE, T1 mapping, and 4DFlow. Exclusion criteria were severe renal failure or other contraindications to CMR. 4DFlow was processed to quantify diastolic components of: i) WSS, ii) time-to-peak WSS (TTP); iii) HF along base-apex (HFba), septal-lateral (HFsl), posterior-anterior (HFpa) directions, the ratio between HFsl and HFba (HFsl-ba). Healthy subjects (n=15, 8 males, age 33±10) served as controls.

Results. Ten treatment naïve amyloid pts with CI (8 males, age 54±11 years) were analyzed (n=7/2/1 in stage III/II/I, Mayo cardiac staging 2004). Pts showed significantly increased LV mass (p<.01), native myocardial T1 (p<.0001), extracellular volume (ECV) and LGE extension (assessed by QALE score) (p<.0001) and decreased LV end-diastolic volume (LVEDV) (p=.01) and ejection fraction (LVEF) (p<0.01) vs controls. WSS was lower and TTP higher in pts vs controls (pNS), also with a significant reduction in all HF components (p<.01). In pts, WSS and HFsl were correlated with left atrial area (r=.88, p<.01; r=.73, p=.01, respectively), and HFsl-ba with EF (r=.73, p=.02). As to tissue characterization, HFsl-ba correlated with myocardial native T1 (r=.71, p=.02). For echo diastolic data, correlation was found between TTP and e/e’ (r=.77, p=.01), HFsl-ba with E/A (r=.80, p<.01) and PAPs (r=.73, p=.02).

Correlation was found between NT-proBNP, cTnI and LV native T1 (r=.82, p=.01; r=.62, p=.05 respectively) and between HFpa and serum free light chain (dFLC), r=.65, p NS.

Conclusions. 4DFlow CMR detected alterations in LV diastolic function in amyloid vs controls. Preliminary analyses highlighted good correlation with CMR tissue characterization, echocardiographic and laboratory markers of diastolic impairment and disease severity.

The free consultation period for this content is over.

It is now only available year-round to EACVI Silver Members, Fellows of the ESC and Young combined Members

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are